Beneficiaries
Novartis Pharma AG (NOVA)
The Novartis Institutes for Biomedical Research (NIBR) in Basel, Switzerland, are part of Novartis’ worldwide research efforts to discover new drugs in Disease Areas that include Oncology, Immunology, Musculoskeletal Diseases, Infectious and Tropical Diseases, Cardiovascular Diseases, and others. Within NIBR, more than 6000 scientists collaborate in interdisciplinary teams to find cures for diseases with high unmet medical need. The Center for Proteomic Chemistry (CPC) with its Structural Biophysics department is part of these efforts, collaborating with Disease Areas and Global Discovery Chemistry.
Supervisor
Dr. Wolfgang Jahnke
Novartis Pharma AG
Center for Proteomic Chemistry
Institutes for Biomedical Research
Novartis Campus
4002 Basel
wolfgang.jahnke(at)novartis.com
www.nibr.com